83-40-9,MFCD00002448
Catalog No.:AA0035R9

83-40-9 | 3-Methylsalicylic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$6.00   $4.00
- +
25g
98%(HPLC)
in stock  
$24.00   $17.00
- +
500g
98%
in stock  
$42.00   $30.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0035R9
Chemical Name:
3-Methylsalicylic acid
CAS Number:
83-40-9
Molecular Formula:
C8H8O3
Molecular Weight:
152.1473
MDL Number:
MFCD00002448
SMILES:
OC(=O)c1cccc(c1O)C
Properties
Properties
 
BP:
234.6°C (rough estimate)  
Form:
Solid  
MP:
98-100 °C(lit.)  
Refractive Index:
1.4945 (estimate)  
Solubility:
methanol: soluble5%, clear to slightly hazy (colorlessto faint brown)  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
155  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.9  

Literature

Title: Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Journal: Journal of medicinal chemistry 20110127

Title: The concept of 'compartment allergy': prilocaine injected into different skin layers.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101

Title: Photophysical properties of lanthanide hybrids covalently bonded to functionalized MCM-41 by modified aromatic carboxylic acids.

Journal: Journal of fluorescence 20090301

Title: In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.

Journal: Bioorganic & medicinal chemistry 20081015

Title: Gene expression-based screening for inhibitors of PDGFR signaling.

Journal: Genome biology 20080101

Title: Mechanisms influencing the vasoactive effects of lidocaine in human skin.

Journal: Anaesthesia 20070201

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Enhanced skin permeation of salicylate by ion-pair formation in non-aqueous vehicle and further enhancement by ethanol and l-menthol.

Journal: Chemical & pharmaceutical bulletin 20060401

Title: Synthesis and characterisation of tungsten(VI) oxo-salicylate complexes for use in the chemical vapour deposition of self-cleaning films.

Journal: Dalton transactions (Cambridge, England : 2003) 20050407

Title: Construction and evaluation of nagR-nagAa::lux fusion strains in biosensing for salicylic acid derivatives.

Journal: Applied biochemistry and biotechnology 20050301

Title: [Anti-inflammatory activity of (o-cresotinate) copper and zinc aquacomplexes].

Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20020701

Title: Substituted alkyne synthesis under nonbasic conditions: copper carboxylate-mediated, palladium-catalyzed thioalkyne-boronic acid cross-coupling.

Journal: Organic letters 20010111

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:83-40-9 Molecular Formula|83-40-9 MDL|83-40-9 SMILES|83-40-9 3-Methylsalicylic acid
Catalog No.: AA0035R9
83-40-9,MFCD00002448
83-40-9 | 3-Methylsalicylic acid
Pack Size: 100mg
Purity: 98%
in stock
$6.00 $4.00
Pack Size: 25g
Purity: 98%(HPLC)
in stock
$24.00 $17.00
Pack Size: 500g
Purity: 98%
in stock
$42.00 $30.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0035R9
Chemical Name: 3-Methylsalicylic acid
CAS Number: 83-40-9
Molecular Formula: C8H8O3
Molecular Weight: 152.1473
MDL Number: MFCD00002448
SMILES: OC(=O)c1cccc(c1O)C
Properties
BP: 234.6°C (rough estimate)  
Form: Solid  
MP: 98-100 °C(lit.)  
Refractive Index: 1.4945 (estimate)  
Solubility: methanol: soluble5%, clear to slightly hazy (colorlessto faint brown)  
Storage: Inert atmosphere;Room Temperature;  
Complexity: 155  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.9  
Literature fold

Title: Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Journal: Journal of medicinal chemistry20110127

Title: The concept of 'compartment allergy': prilocaine injected into different skin layers.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology20110101

Title: Photophysical properties of lanthanide hybrids covalently bonded to functionalized MCM-41 by modified aromatic carboxylic acids.

Journal: Journal of fluorescence20090301

Title: In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.

Journal: Bioorganic & medicinal chemistry20081015

Title: Gene expression-based screening for inhibitors of PDGFR signaling.

Journal: Genome biology20080101

Title: Mechanisms influencing the vasoactive effects of lidocaine in human skin.

Journal: Anaesthesia20070201

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Enhanced skin permeation of salicylate by ion-pair formation in non-aqueous vehicle and further enhancement by ethanol and l-menthol.

Journal: Chemical & pharmaceutical bulletin20060401

Title: Synthesis and characterisation of tungsten(VI) oxo-salicylate complexes for use in the chemical vapour deposition of self-cleaning films.

Journal: Dalton transactions (Cambridge, England : 2003)20050407

Title: Construction and evaluation of nagR-nagAa::lux fusion strains in biosensing for salicylic acid derivatives.

Journal: Applied biochemistry and biotechnology20050301

Title: [Anti-inflammatory activity of (o-cresotinate) copper and zinc aquacomplexes].

Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti20020701

Title: Substituted alkyne synthesis under nonbasic conditions: copper carboxylate-mediated, palladium-catalyzed thioalkyne-boronic acid cross-coupling.

Journal: Organic letters20010111

Building Blocks More >
15442-91-8
15442-91-8
1,2,4,5-Tetrakis(bromomethyl)benzene
AA0035UX | MFCD00009664
70639-77-9
70639-77-9
2-Oxo-1,2,3,4-tetrahydroquinoline-6-carboxylic acid
AA0035XY | MFCD08271842
21810-34-4
21810-34-4
Potassium 6-hydroxyhexanoate
AA00361G | MFCD27920725
32263-70-0
32263-70-0
6-(Benzyloxy)-3,4-dihydronaphthalen-1(2h)-one
AA00364S | MFCD12024333
885702-33-0
885702-33-0
2-Bromo-4-chloropyrimidine
AA00367Z | MFCD11847634
86505-94-4
86505-94-4
Methyl 2-amino-6-fluorobenzoate
AA0036B0 | MFCD01763810
791595-74-9
791595-74-9
5-bromo-1H-1,3-benzodiazol-2-amine
AA0036E8 | MFCD06659788
73-31-4
73-31-4
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide
AA0036H8 | MFCD00005655
76095-16-4
76095-16-4
Enalapril maleate salt
AA0036KF | MFCD00133304
7311-70-8
7311-70-8
2,5-Dibromothiophene-3-carboxylic acid
AA0036NT | MFCD08445656
Submit
© 2017 AA BLOCKS, INC. All rights reserved.